The importance of developing new mannan tests in the diagnosis of invasive candidiasis in oncology patients

The regimens of anticancer therapy have been intensified and methods of high-dose chemotherapy (HDCT) have been introduced for recent years which made it possible to achieve significant progress in the results of tumor treatments. Intensification of chemotherapy regimens in cancer patients leads to the emergence of risk factors of invasive candidiasis (IC) development: agranulocytosis, disruption of the integrity of the mucous membranes, prolonged use of CVC, repeated antibiotic therapy, long-term parenteral nutrition. Thus, intensification of anticancer therapy may be accompanied by an increase in infection-mediated mortality.
IC is the most common invasive mycosis in Russia. More than 11 thousand cases of IC occur in our country every year. The frequency IC in Russia is 8.29 per 100 thousand of the population, which corresponds to the results of the LIFE study in European countries where this indicator varies from 2.2 to 11 per 100 thousand of the population. There are no clinical signs or symptoms specific for IC. It develops in patients with concomitant diseases, which significantly complicates the diagnosis. In this regard, an urgent issue is to improve the diagnosis of candidal infectious complications in cancer patients in order to optimize treatment by studying serological markers that have the greatest value in the diagnosis of infectious complications in cancer patients.

1. Dinikina YuV, Shadrivova OV, Belogurova MB, Ignatyeva SM, Bogomolova TS, Klimko NN. Breakthrough invasive candidiasis in pediatric patient with Ewing’s sarcoma: dinical case report and literature review. Oncohematology. 2019;14(4):59– 66. (In Russian). https://doi.org/10.17650/1818-8346-2019-14-4-59-66

2. Mikhalkina EV, Skachkova LS, Kit OI, Fomenko YuA. Socio-economic predictors of cancer. Journal of Institutional Research. 2020;12(3):122–141. (In Russian). https://doi.org/10.17835/2076-6297.2020.12.3.122-141

3. Klimko NN, Kozlova YaI, Khostelidi SN, Shadrivova OV, Borzova YuV, Vasileva NV. The prevalence of serious and chronic fungal diseases in russian federation on life program model. Problems of medical mycology. 2014;16(1):3–8. Available at: https://mycology.szgmu.ru/files/MAPO_1_2014.pdf. Accessed: 16.05.2021. (In Russian).

4. Bongomin F, Gago S, Oladele RO, Denning DW. Global and Multi-National Prevalence of Fungal Diseases-Estimate Precision. J Fungi (Basel). 2017 Oct 18;3(4):E57. https://doi.org/10.3390/jof3040057

5. Brown GD, Denning DW, Gow NAR, Levitz SM, Netea MG, White TC. Hidden killers: human fungal infections. Sci Transl Med. 2012 Dec 19;4(165):165rv13. https://doi.org/10.1126/scitranslmed.3004404

6. Invasive candidiasis in newborns. Clinical Guidelines of the Ministry of Health of the Russian Federation. Moscow, 2017, 34 p. Available at: https://dzhmao.ru/spez/klin_recom/neonatologiya/invazKandidoz.pdf. Accessed: 16.05.2021. (In Russian).

7. Diagnosis and treatment of mycoses in intensive care units: Russian recommendations. Ed. by N. N. Klimko. 2nd ed. additional and re-edited by M.: Farmtek, 2015, 96 p. Available at: http://nasci.ru/?id=2269&download=1. Accessed: 16.05.2021. (In Russian).

8. Wisplinghoff H, Bischoff T, Tallent SM, Seifert H, Wenzel RP, Edmond MB. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis. 2004 Aug 1;39(3):309–17. https://doi.org/10.1086/421946

9. Magill SS, Edwards JR, Bamberg W, Beldavs ZG, Dumyati G, Kainer MA, et al. Multistate point-prevalence survey of health care-associated infections. N Engl J Med. 2014 Mar 27;370(13):1198–1208. https://doi.org/10.1056/NEJMoa1306801

10. Arastehfar A, Carvalho A, Nguyen MH, Hedayati MT, Netea MG, Perlin DS, et al. COVID-19-Associated Candidiasis (CAC): An Underestimated Complication in the Absence of Immunological Predispositions? J Fungi (Basel). 2020 Oct 8;6(4):E211. https://doi.org/10.3390/jof6040211

11. Kullberg BJ, Arendrup MC. Invasive Candidiasis. N Engl J Med. 2015 Oct 8;373(15):1445–1456. https://doi.org/10.1056/NEJMra1315399

12. Kutsevalova O, Antonets A, Kit O, Panova N, Lysenko I, Dmitrieva V, Pak E, Kozyuk O, Marykov E, Klyasova G. New approaches to the verification of bacterial and candidal bloodstream infection. J. Fungi. 2019 Dec;5(4):208–210. https://doi.org/10.3390/jof5040095

13. Morrell M, Fraser VJ, Kollef MH. Delaying the empiric treatment of candida bloodstream infection until positive blood culture results are obtained: a potential risk factor for hospital mortality. Antimicrob Agents Chemother. 2005 Sep;49(9):3640–3645. https://doi.org/10.1128/AAC.49.9.3640-3645.2005

14. Garey KW, Rege M, Pai MP, Mingo DE, Suda KJ, Turpin RS, et al. Time to initiation of fluconazole therapy impacts mortality in patients with candidemia: a multi-institutional study. Clin Infect Dis. 2006 Jul 1;43(1):25–31. https://doi.org/10.1086/504810

15. Clancy CJ, Nguyen MH. Finding the “missing 50%” of invasive candidiasis: how nonculture diagnostics will improve understanding of disease spectrum and transform patient care. Clin Infect Dis. 2013 May;56(9):1284–1292. https://doi.org/10.1093/cid/cit006

16. Kolupaev VE, Sokolinskaya IYu. The role of determining the mannan antigen and antibodies to manan in the diagnosis of invasive candidiasis. Remedium Privolzhye. 2015;4(134):34–35. https://www.remedium.ru/upload/iblock/023/Remedium_4.15%20SMALL.pdf

17. Mikulska M, Calandra T, Sanguinetti M, Poulain D, Viscoli C, Third European Conference on Infections in Leukemia Group. The use of mannan antigen and anti-mannan antibodies in the diagnosis of invasive candidiasis: recommendations from the Third European Conference on Infections in Leukemia. Crit Care. 2010;14(6):R222. https://doi.org/10.1186/cc9365

18. 18. De Pauw B, Walsh TJ, Donnelly JP, Stevens DA, Edwards JE, Calandra T, et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis. 2008 Jun 15;46(12):1813–1821. https://doi.org/10.1086/588660

19. León C, Ruiz-Santana S, Saavedra P, Castro C, Loza A, Zakariya I, et al. Contribution of Candida biomarkers and DNA detection for the diagnosis of invasive candidiasis in ICU patients with severe abdominal conditions. Crit Care. 2016 May 16;20(1):149. https://doi.org/10.1186/s13054-016-1324-3

20. Verduyn Lunel FM, Donnelly JP, van der Lee H. L, Blijlevens NMA, Verweij PE. Circulating Candida-specific anti-mannan antibodies precede invasive candidiasis in patients undergoing myelo-ablative chemotherapy. Clin Microbiol Infect. 2009 Apr;15 (4):380–386. https://doi.org/10.1111/j.1469-0691.2008.02654.x

21. Duettmann W, Koidl C, Krause R, Lackner G, Woelfler A, Hoenigl M. Specificity of mannan antigen and anti-mannan antibody screening in patients with haematological malignancies at risk for fungal infection. Mycoses. 2016 Jun;59(6):374–378. https://doi.org/10.1111/myc.12482

22. Pappas PG, Kauffman CA, Andes DR, Clancy CJ, Marr KA, Ostrosky-Zeichner L, et al. Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America. Clin Infect Dis. 2016 Feb 15; 62 (4): e1-50. https://doi.org/10.1093/cid/civ933

23. Charushina IP, Feldblum IV, Vorobyeva NN, Balandina SYu, Kuznetsova MV, Verbitskaya TA. Invasive candidiasis in HIV-infected patients. Federal clinical recommendations. Moscow, 2017, 46 p. http://nasci.ru/?id=2883

24. Noskova OA, Agapova ED, Baturina EA, Gvak GV. Microbiological Monitoring in the System of Epidemiological Surveillance of Purulent-Septic Infections in a Multidisciplinary Hospital. Acta Biomedica Scientifica. 2019;4(5):122–126. (In Russian). https://doi.org/10.29413/ABS.2019-4.5.19

25. Gusarov VG, Lashenkova NN, Petrova NV, Dementienko MV, Shilkin DN, Nesterova EE, et al. Protocols of empirical antimicrobial therapy in improving quality of emergency medical care to patients with infection in multidisciplinary surgical hospital. Medical Alphabet. 2016;4(33(296)):24–28.